Aviva’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-47,600
Closed -$422K 1010
2022
Q3
$422K Buy
47,600
+2,100
+5% +$26.4K ﹤0.01% 955
2022
Q2
$575K Buy
45,500
+4,400
+11% +$56K ﹤0.01% 1012
2022
Q1
$778K Buy
41,100
+500
+1% +$12.7K ﹤0.01% 992
2021
Q4
$1.42M Buy
40,600
+9,300
+30% +$302K 0.01% 906
2021
Q3
$1.14M Buy
31,300
+8,400
+37% +$330K 0.01% 931
2021
Q2
$899K Hold
22,900
﹤0.01% 814
2021
Q1
$647K Sell
22,900
-900
-4% -$28.7K ﹤0.01% 913
2020
Q4
$762K Buy
23,800
+700
+3% +$21.5K ﹤0.01% 876
2020
Q3
$746K Sell
23,100
-1,000
-4% -$31.2K ﹤0.01% 865
2020
Q2
$665K Buy
24,100
+3,300
+16% +$71.6K ﹤0.01% 903
2020
Q1
$371K Sell
20,800
-800
-4% -$19.3K ﹤0.01% 905
2019
Q4
$542K Buy
21,600
+3,900
+22% +$85.4K ﹤0.01% 922
2019
Q3
$316K Buy
17,700
+1,400
+9% +$29.2K ﹤0.01% 772
2019
Q2
$359K Buy
16,300
+700
+4% +$20K ﹤0.01% 776
2019
Q1
$477K Buy
15,600
+3,500
+29% +$87.3K ﹤0.01% 731
2018
Q4
$279K Buy
+12,100
New +$376K ﹤0.01% 733

Other funds holding HCM

Aviva's HCM Position: Q4 2022 in Review

Aviva sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 47,600 shares — an estimated $422K sold.

Aviva first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $1.42M in Q4 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Aviva reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Aviva sold 47,600 HUTCHMED shares in Q4 2022, an estimated $422K.
  • Aviva first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • Aviva's HUTCHMED position peaked at $1.42M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.